Showing results (131-140 of 776) with videos related to
Sort By:
Pageof 78
The American Journal of Cardiology|September 1, 1987
Coronary arterial thrombolysis with low-dose synergistic combinations of recombinant tissue-type plasminogen activator (rt-PA) and recombinant single-chain urokinase-type plasminogen activator (rscu-PA) for acute myocardial infarctionD Collen, F Van de WerfCirculation|June 1, 1993
Coronary thrombolysis with recombinant staphylokinase in patients with evolving myocardial infarctionD Collen, F Van de WerfJournal of Thrombosis and Haemostasis : JTH|August 31, 2004
Comparative effects of microplasmin and tissue-type plasminogen activator (tPA) on cerebral hemorrhage in a middle cerebral artery occlusion model in miceY Suzuki, N Nagai, D CollenBlood|January 1, 1987
Measurement of free, one-chain tissue-type plasminogen activator in human plasma with an enzyme-linked immunosorbent assay based on an active site-specific murine monoclonal antibodyP Holvoet, J Boes, D CollenThrombosis and Haemostasis|October 30, 1985
Assay of human tissue-type plasminogen activator (t-PA) with an enzyme-linked immunosorbent assay (ELISA) based on three murine monoclonal antibodies to t-PAP Holvoet, H Cleemput, D CollenCirculation|December 22, 1999
Comparative effects of tissue plasminogen activator, streptokinase, and staphylokinase on cerebral ischemic infarction and pulmonary clot lysis in hamster modelsN Nagai, I Vanlinthout, D CollenCardiovascular Research|October 9, 1998
Mouse models of angiogenesis, arterial stenosis, atherosclerosis and hemostasisP Carmeliet, L Moons, D CollenThe Veterinary Clinics of North America. Small Animal Practice|June 28, 2005
Mandibulectomy and maxillectomyFrank J M VerstraeteActa Cardiologica|January 1, 1979
Medical treatment in intermittent claudicationR Verhaeghe, M VerstraetePageof 78